1048. Double-Blind, Randomized, Placebo-Controlled Phase 2b Multicenter Trial of V160, a Replication-Defective Human Cytomegalovirus (CMV) Vaccine

por Das, Rituparna, Blazquez-Gamero, Daniel, Bernstein, David I, Gantt, Soren, Bautista, Oliver, Beck, Karen, Conlon, Anthony, Rosenbloom, Daniel, Wang, Dai, Ritter, Michael, Arnold, Beth, Annunziato, Paula, Russell, Kevin
Publicado 2021

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

por Boeckh, Michael J, Arvin, Ann M, Mullane, Kathleen M, Camacho, Luis H, Winston, Drew J, Morrison, Vicki A, Hurtado, Kimberly, Durrand Hall, Jessie, Pang, Lei, Su, Shu-Chih, Kaplan, Susan S, Annunziato, Paula W, Popmihajlov, Zoran
Publicado 2020

Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-...

por Robbins, Jonathan A., Tait, Dereck, Huang, Qinlei, Dubey, Sheri, Crumley, Tami, Cote, Josee, Luk, Julie, Sachs, Jeffrey R., Rutkowski, Kathryn, Park, Harriet, Schwab, Robert, Howitt, William Joseph, Rondon, Juan Carlos, Hernandez-Illas, Martha, O'Reilly, Terry, Smith, William, Simon, Jakub, Hardalo, Cathy, Zhao, Xuemei, Wnek, Richard, Cope, Alethea, Lai, Eseng, Annunziato, Paula, Guris, Dalya, Stoch, S. Aubrey
Publicado 2022